Brief: Evolent Health Reaffirms Previously Issued Guidance For Year Ended Dec 31, 2022
11/01/2023 11:28
Jan 11 (Reuters) - Evolent Health Inc EVH.N :
* EVOLENT HEALTH INC - REAFFIRMING PREVIOUSLY ISSUED REVENUE
AND
ADJUSTED EBITDA GUIDANCE FOR YEAR ENDED DEC 31, 2022
Source text: (https://bit.ly/3ZpYbzf)
Further company coverage: EVH.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows